Akero Therapeutics Inc. (AKRO)
Akero Therapeutics Max Pain By Strike
AKRO trades at $49.42, 4.0% above the near-term max pain of $47.5 expiring Aug 15, 2025 (0 days). Price stability likely with balanced options positioning at this level. Max pain is stable across expirations ($30-$50), indicating stable market expectations. Key magnetic zone at 50 where 3 expirations converge.
Akero Therapeutics Max Pain By Expiry
Max pain for AKRO shows stable levels around 42.92, reflecting balanced market expectations. The 47% spread signals divergent expectations across timeframes. Levels distributed around 49.42. Strong magnetic level at 50 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 47.5 | -1.92 (-3.89%) |
| Sep 19, 2025 | 50 | 0.58 (1.16%) |
| Oct 17, 2025 | 30 | -19.42 (-39.30%) |
| Nov 21, 2025 | 50 | 0.58 (1.16%) |
| Jan 16, 2026 | 30 | -19.42 (-39.30%) |
| Feb 20, 2026 | 50 | 0.58 (1.16%) |